Moore Alexander D. sold $2.1M of PLTR

Moore Alexander D. sold 16,000 shares of Palantir Technologies Inc. (PLTR) at an average of $133.35 ($130.48–$134.44, $2.13M total) across 5 trades on 2026-06-15 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Moore Alexander D.
Published Jun 18, 2026, 12:00 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 18, 2026, 12:04 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$PLTR
Neutral
medium confidence
Mentioned
$PLTR
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$PLTRNeutralLow
01

Why it matters

The disclosed open-market sale (~$2.13M) is likely to be interpreted as routine planned selling; it may cause minor near-term sentiment noise but lacks new company fundamentals.

02

Market read

Traders may monitor for follow-on insider activity, but this specific disclosure alone is unlikely to drive a durable repricing.

03

What to watch

The article doesn’t state whether other insiders sold/bought around the same time, nor does it quantify total insider net activity beyond this single director’s sale.

Relevance 5/10Novelty 5/10Timing: Filed 2026-06-17 for a 2026-06-15 sale; information becomes actionable on disclosure date.

Background

The filing is an SEC Form 4 insider transaction for Palantir director Moore Alexander D., executed under a pre-arranged Rule 10b5-1 plan.

Company-level read

Ticker impact

$PLTRNeutralMedium confidence
Context

Palantir director Moore Alexander D. sold 16,000 shares in an open-market transaction on a 10b5-1 plan for ~$2.13M at ~$130.48–$134.44.

Expected impact

Low likelihood of sustained price impact; any reaction is likely short-lived unless paired with other news.

Evidence & confidence

The disclosure is a Form 4 insider sale under a pre-arranged 10b5-1 plan, with no accompanying operational/regulatory/financial change described.

Market effects

Minimal read-through to the software/AI sector; this is company-specific insider activity without new guidance or contract details.

No clear regional spillover; US-listed issuer with routine insider transaction disclosure.

Limited global relevance absent any international deal, regulation, or earnings/guidance change.

Counterpoint

Even 10b5-1 sales can coincide with periods of elevated valuation; traders may still use the timing as a sentiment check rather than a fundamental signal.

Key entities

  • Palantir Technologies Inc.

    US-listed company whose director executed a planned open-market sale disclosed via SEC Form 4.

  • Moore Alexander D.

    Director who sold 16,000 shares across five trades on 2026-06-15 under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$PLTRHighAI 8/10

Palantir (PLTR) Stock Falls Despite 96% Revenue Surge, Can Its Climate Goals Keep Up?

Palantir (PLTR) reported Q3 2026 revenue of $2.3B, up 96% YoY, and raised its full-year outlook. Despite beating estimates, shares fell due to slower contract growth and high expectations. The company's emissions rose 18% in 2025, though still below its 2019 baseline. Palantir aims for carbon neutrality but faces challenges managing Scope 3 emissions, primarily from business travel.

$PLTRMed

Defense Tech Guidance Moves Higher With a Dec. 11 Funding Deadline Ahead

Palantir's U.S. commercial revenue surpassed government revenue for the first time in Q3, while Booz Allen, CACI, and BigBear.ai reported larger backlogs and raised full-year targets. Parsons narrowed its guidance. Federal funding deadline is Dec. 11, with budget uncertainty lingering. Palantir reported $2.313B Q3 revenue, raising FY2026 guidance to $8.530B-$8.534B. Booz Allen's Q2 revenue was $2.8B, with raised EPS guidance. CACI's Q1 revenue was $2.5B, with raised FY2027 revenue guidance.